Categories Uncategorized

SinglePoint, Inc. (SING) Riding High as New CBD Products Enter Fast Growing Legal Marketplace

  • SinglePoint’s cannabis market subsidiaries building direct-to-consumer supply chain for CBD products
  • SingleSeed subsidiary introduced infused water and muscle salve products in October, with new sleep aid and a hair and beard oil expected promptly
  • CBD is gaining traction as a medicinal product and wellness industry ingredient after Canada’s legalization drive and growing lawfulness in the United States

Technology innovator SinglePoint, Inc. (OTCQB: SING) is celebrating the rollout of new products to the cannabis-infused wellness market by subsidiary SingleSeed at the same time that its already-launched Lalpina CBD Water is reporting a successful first week of sales.

SingleSeed distributes hemp-based CBD (cannabidiol) products on a direct-to-consumer basis nationwide, and its website has only just begun offering its Cannasporin Muscle Salve and easy applicator Twist-Up Stick to soothe and heal damaged muscles as it reduces inflammation, while a CBD hair and beard oil and a new sleep aid tincture are expected in the coming weeks (http://cnw.fm/Rx94O).

Lalpina CBD Water comes in a 12-pack case and received 25 orders within the first week. Those transactions also helped drive the sales of other SingleSeed products, the company reported (http://cnw.fm/9Vt7D).

“We are thrilled at this first week of sales results, it has blown away our expectations especially when taking into consideration we have not yet added it to our mix of search marketing, most of the orders have been organic direct search for SingleSeed.com,” SinglePoint President Wil Ralston stated in the report.

SinglePoint specializes in acquiring small to mid-sized companies, emphasizing new technologies and providing investors opportunities to monetize assets ranging from payment processing and cannabis services to blockchain technologies and a cryptocurrency app co-created with AppSwarm (OTC: SWRM).

The new spate of SingleSeed’s CBD products are fulfilled directly by another SinglePoint subsidiary, Discount Indoor Garden Supply (“DIGS” or “DIGS Hydro”), which is able to provide bulk CBD from raw to “pure” isolate concentrated extract, as well as supplying white-labeled products.

In the wake of Canada’s nationwide legalization of all adult uses of cannabis in mid-October, SinglePoint is now exploring the ramifications of entering the Canadian market for a dual listing.

The company notes in its publications that Hemp Business Journal’s CBD market forecast anticipates growth to $2.1 billion by 2021, with $450 million of those sales coming from hemp-based sources (http://cnw.fm/bMC42). That provides a situation rife with opportunity to capitalize on e-commerce and physical outlets.

The CBD market is not only finding fertile ground in Canada’s legalization drive, but across the United States, where more than half of the states have established some type of authority for CBD use in medicinal applications. Because CBD’s chemically active properties do not produce the drugged euphoria of marijuana sibling tetrahydrocannabinol (THC) and because its users affirm that it provides relief from some chronic conditions, it is also gaining ground legislatively on the federal level. Congress is working toward a bipartisan approval of the 2018 Farm Bill, which would allow CBD-rich hemp to be grown as an agricultural commodity instead of a proscribed drug (http://cnw.fm/E04ur), and the U.S. Food and Drug Administration recently approved a cannabis-based anti-seizure medication for pharmaceutical distribution, which drove the U.S. Drug Enforcement Administration to reclassify CBD as medicinal and legal in FDA-approved uses for the first time (http://cnw.fm/VW3Ze).

For more information, visit the company’s website at www.SinglePoint.com

More from CannabisNewsWire

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

USDA Says Hemp Harvests, Prices are Rising

A recent report by the U.S. Department of Agriculture points to the hemp industry becoming…

2 days ago

Home Office Overhauls Licensing Framework for Hemp in UK

The Home Office recently made changes to its licensing framework for the industrial hemp industry.…

5 days ago

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human…

5 days ago

Kansas Lawmakers Discuss Proposal to Jail Farmers Growing ‘Hot Hemp’

Local prosecutors in Kansas working in collaboration with one lobbyist and law enforcement are discussing…

1 week ago

Federal Study Finds 9 in 10 Samples of Smokable Hemp Exceed THC Limits

The cultivation and manufacture of hemp has burgeoned since the crop was legalized under the…

2 weeks ago

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio to 41; Maintains Focus on GLP-1 Clinical Studies for 2024

Lexaria, a global innovator in drug delivery platforms, has added three new patents to its…

2 weeks ago